Taysha Gene Therapies (TSHA) Earnings Date & Reports
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TSHA is expected to report earnings to rise 30.43% to -9 cents per share on May 07
Q1'25
Est.
$-0.09
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.01
The last earnings report on February 26 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 2.80M shares outstanding, the current market capitalization sits at 260.35M.